FDA MedWatch e-mail updates Concise, timely information about the drugs and devices you use, prescribe, or dispense every day, directly from the U.S. FDA.
DailyMedNational Library of Medicine's database of standard, up-to-date information about marketed drugs, including FDA approved labels (package inserts). NLM regularly processes data files uploaded from FDA's system and provides and maintains this Web site for the public to use in accessing the information. Additional information about medicines is available on NLM's MedlinePlus Web site http://www.nlm.nih.gov/medlineplus/medicines.html.
WebMD Drugs & Medications A-Z Over the counter medicines can also have psychiatric or behavioral side effects, which may not be listed on product packaging or product websites. Check here for possible side effects. Click on the "Does [name of drug] have any side effects?" box after clicking on the "Side Effects" tab.
consumermedsafety.org Brought to you by the Institute for Safe Medication Practices (ISMP) - the nation's only nonprofit organization of pharmacists, nurses, and doctors devoted entirely to safe medication practices. Preventing medication errors is no longer just a responsibility for health professionals - consumers like you can also play a vital role.
Clinicaltrials.gov registry of federally and privately supported clinical trials conducted in the United States and around the world. Information about a trial's purpose, who may participate, locations, and phone numbers for more details.
Federal Register the official daily publication for rules, proposed rules, and notices of Federal agencies and organizations, as well as executive orders and other presidential documents.
Regulations.gov Source for all regulations (or rulemakings) issued by U.S. government agencies, open for public comment (i.e., proposed rules) and closed for comment (i.e., final rules) as published in the Federal Register.
Canadian "Product Monograph" for SingulairHYPERKINESIA was reported as a drug related adverse experience in >1% of patients treated with SINGULAIR and at a greater incidence than in patients treated with placebo in a clinical study of 175 pediatric patients 6 months to 2 years of age, This information is not included in the "Adverse Reactions" section of Singulair's US label.
Montelukast and Churg-Strauss Syndrome Turkish Respiratory Journal, Füsun Topçu, Levent Akyıldız, Tekin Yıldız, Kenan İltumur, Faruk Oktay, Nihal Kılınç.CSS does not appear to relate to steroid tapering in our patient. Long-term data on these drugs are lacking and leukotriene's role in vasculitis remains to be elucidated. Cardiac involvement in CSS, may present as a serious course. The blockade of the cysteinyl leukotriene receptors could provoke an imbalance in leukotriene receptor stimulation, leading to an increase in circulating LTB4. This leukotriene is a strong chemoattractant for neutrophils and eosinophils and could trigger an eosinophilic state, and thereby intitiate vasculitic involvement.
Churg–Strauss syndrome and leukotriene antagonist use: a respiratory perspective Thorax Online, May 2008, N. Nathani, M A Little, H Kunst, D Wilson, D R Thickett. Authors conclude that based on the available clinical evidence there is a suggestion of a causal relationship between LTA and CSS. Respiratory physicians need to be aware of the risk of CSS when treating patients with asthma with LTAs. Patients should be made aware of the signs and symptoms of CSS after initiation of LTA therapy and they should be regularly monitored for complications.
Montelukast and Churg-Strauss syndrome Swiss Med Weekly, 2004, David Conena, Jörg Leuppib, Lukas Bubendorfc, Anke Ronsdorfa, Michael Tammb, Thomas Hauserd. Almost 150 cases of LRA associated CSS have been reported by the US FDA...An as yet unknown direct pathogenic effect of these drugs appears to be possible...Given the various, inconclusive reports, a controlled study with a large number of patients is needed...clinicians should be aware of this rare but potentially severe complication of LRA.
Churg–Strauss syndrome in two patients receiving montelukast Oxford Journals, Rheumatology 2002, P. Guilpain, J.-F. Viallard, P. Lagarde, P. Cohen, M. Kambouchner, J.L. Pellegrin and L. Guillevin. Both patients presented with CSS after 4–5 months of treatment with montelukast. Neither patient received long-term systemic steroids for asthma, but both were on inhaled steroids.
Montelukast and Churg-Strauss syndrome Thorax online 2002, R Solans, J A Bosch, A Selva, R Orriols, M Vilardell. To our knowledge, no case of CSS relapse has previously been reported in association with leukotriene antagonists.
Asthma Risk for Behavioral, Emotional, Developmental Problems Researchers at the University of Virginia Children's Hospital evaluated data collected in a survey conducted by the Centers for Disease Control and Prevention. According to the study, parents of kids with asthma were twice as likely to report that their child has severe problems with behavior, emotions, concentration, or getting along with others. THIS ARTICLE DOES NOT DISCUSS THE ROLE OF ASTHMA MEDICATIONS AS A CONTRIBUTING FACTOR.
INFORMATION ABOUT COMPLIMENTARY AND ALTERNATIVE TREATMENTS FOR ASTHMA AND ALLERGIES
Asthma is a serious disease. If you decide to treat your or your child's asthma symptoms with natural products, consult a licensed health professional. Supplements and herbs can be harmful if used incorrectly.